CD4 and Autoimmunity: In conclusion, if we want to take advantage of the powerful regulatory action of miRNAs for therapeutic purposes, in the next years we will have to fully untangle the intricate web of miRNA-target genes to safely re-direct the differentiation and function of CD4+ Th cell subsets in pathological conditions such as autoimmunity.